nitroglycerin has been researched along with urb 597 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Markert, A; Nozaki, C; Zimmer, A | 1 |
Demartini, C; Greco, R; Misto, A; Piomelli, D; Reggiani, A; Tassorelli, C; Tumelero, E; Zanaboni, AM | 1 |
2 other study(ies) available for nitroglycerin and urb 597
Article | Year |
---|---|
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice.
Topics: Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Benzamides; Cannabinoid Receptor Antagonists; Carbamates; Disease Models, Animal; Dose-Response Relationship, Drug; Endocannabinoids; Enzyme Inhibitors; Hyperalgesia; Male; Mice, Inbred C57BL; Mice, Knockout; Migraine Disorders; Monoacylglycerol Lipases; Nitroglycerin; Pain Measurement; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant; Touch; Trigeminal Nuclei | 2015 |
FAAH inhibition as a preventive treatment for migraine: A pre-clinical study.
Topics: Amidohydrolases; Animals; Benzamides; Carbamates; Disease Models, Animal; Male; Migraine Disorders; Nitroglycerin; Rats; Rats, Sprague-Dawley; Trigeminal Caudal Nucleus; Vasodilator Agents | 2020 |